NMRA
Neumora Therapeutics, Inc. · Healthcare
Arch Venture Partners Xii, LLC bought $1.1M of Neumora Therapeutics, Inc.
10% owner
Bought$1,127,064
$11.19Price
100,740Shares
+3%Stake
What NMRA did for a copier
- $1,000 copied at Tue, Sep 26 open, $11.40
- $1,018
- S&P 500, same days
- +1.8%
Measured over 30 trading days, to the Nov 7 close.
Arch Venture Partners Xii, LLC's record
7 other buys with 3 months of prices since 2023: on average +1.1% against the S&P 500, and 4 of 7 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Sep 22. Filed Mon, Sep 25, 9:38 PM ET, after the close. Returns use the Sep 26 open and the Nov 7 close. Not investment advice.